Addressing COVID-19 vaccine hesitancy: is official communication the key?

Michaël Schwarzinger, Stéphane Luchini
Author Information
  1. Michaël Schwarzinger: Department of Methodology and Innovation in Prevention, Bordeaux University Hospital, 33000 Bordeaux, France; University of Bordeaux, Inserm UMR 1219-Bordeaux Population Health, Bordeaux, France. Electronic address: michael.schwarzinger@chu-bordeaux.fr.
  2. Stéphane Luchini: Aix-Marseille University, National Centre for Scientific Research (CNRS), School of Advanced Studies in the Social Sciences (EHESS), Ecole Centrale Marseille, Aix-Marseille School of Economics (AMSE), Marseille, France.

Abstract

No abstract text available.

References

  1. Eur J Soc Psychol. 2021 Mar;51(2):285-293 [PMID: 33821057]
  2. Lancet Public Health. 2021 Jun;6(6):e416-e427 [PMID: 33991482]
  3. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  4. Psychol Med. 2022 Oct;52(14):3127-3141 [PMID: 33305716]
  5. Lancet Public Health. 2021 Apr;6(4):e210-e221 [PMID: 33556325]
  6. Nature. 2020 Jun;582(7811):230-233 [PMID: 32499650]
  7. J Public Health (Oxf). 2021 Dec 10;43(4):695-702 [PMID: 33693905]
  8. Public Health. 2021 May;194:86-88 [PMID: 33866149]
  9. R Soc Open Sci. 2020 Oct 14;7(10):201199 [PMID: 33204475]

MeSH Term

COVID-19
COVID-19 Vaccines
Communication
Humans
SARS-CoV-2
Single-Blind Method
United Kingdom
Vaccination

Chemicals

COVID-19 Vaccines